Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
about
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancerEpidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantationAcyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover studyA systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyAcyclovir prophylaxis for herpes simplex virus infection.Pharmacokinetics of acyclovir suspension in infants and children.Antiviral therapy: current concepts and practicesAntiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Management of oral mucositis in patients who have cancerAcyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trialPharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infectionHerpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.Using antimicrobial adjuvant therapy in cancer treatment: a review.The current spectrum of infection in cancer patients with chemotherapy related neutropenia.Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties.Nobel Lecture. The purine path to chemotherapy.A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy.Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions.Viral infections in severely immunocompromised cancer patients.Viral infections in leukemia and bone marrow transplant patients.Analysis of early infectious complications after autologous bone marrow transplantation.Supportive therapy in management of leukemias.Impact of herpesvirus infections in the future.Chemotherapy of herpesvirus infections: present successes and future hopes.Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia.Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT.
P2860
Q24241443-D491E598-9912-4918-8EFE-1A76F13741C9Q33559473-242B4638-0A60-42C7-B1D0-AE3C25A52FEAQ33582991-E0AEBE1C-F882-438B-9C92-0645B27039B7Q34120597-990DBC6E-2F12-4CBA-9643-15DCA0DC3521Q34316358-EB281C5F-106D-48D2-A0CE-FBA5782180B4Q34579981-166A6353-C734-44B6-8818-3375EC2F8CDBQ35537506-F1907C41-8C59-42DC-8650-2CBB5BCCE808Q35543240-95DEFD3D-36FA-4F89-8044-8FEED6A03AEAQ36070394-DE4DA8B1-7F74-444E-90C6-C0740B4BFFCBQ36367268-45E124C0-96BD-49A6-B9E2-B02B3B6B3F06Q36494114-06272992-6652-4BD9-9D03-BDA8F35A2DFDQ36903422-3302316D-7C8A-4483-8C1C-352233DFD83FQ37190818-7EB13F21-301D-4003-B2C5-62608275A0B7Q37901418-88CFBC5D-A0A2-4807-A373-4DFC8F2760F4Q38060894-F21F7570-8D19-4BE3-AD4A-61F227DD8F97Q38131442-A56F2711-560A-4DA1-8603-A4AAA8E9C7AAQ38425424-05C47E1E-8C8D-4AB7-8DE0-2BD5FBB387EEQ38707737-7FAEFABB-9968-41AA-9D33-517E773A7282Q39010658-0E14F5A7-872E-49A0-A533-0DD68D38CBD5Q39247468-3A3C266D-0E26-449A-B8D5-80B2CB747591Q39634295-E63B3DCA-237E-43DB-8F0F-43F0B3EF8F9BQ40284011-7442DA33-9B45-42B3-B51E-7B7D5AE89155Q40594928-AAE8B600-B294-4EBD-98AE-9662FE663BEFQ40722959-04251043-A3C9-49D9-90F5-857DDAA5651AQ40781788-A461F321-7DF4-497B-921C-CB6F7EBA3926Q40781975-C0E771C7-7E0A-429C-8F06-76CB4737CE51Q40782490-8B4A8FCC-AC26-4EA6-98F6-877279FF5765Q41374911-A6690EB9-D56B-4686-9223-425A32E0DF4AQ42286838-02BA0D17-4298-41B6-B6F2-9400EF567238Q44157452-EC1E5C92-73FA-481F-86AF-AA1D52EB6D56Q45129270-6D117787-9A8D-411E-B56F-2804523DBDACQ45782525-EF25C345-2512-4A2F-8E66-6D89DF4D2D8AQ45831033-FDFB143E-9BDE-42D9-8B76-642048D6BE6FQ48406876-25B74A76-F8FD-403D-83A2-C4D71DC1D917Q51680741-338308E4-FE68-4227-88C3-C295230A3929
P2860
Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@en
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@nl
type
label
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@en
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@nl
prefLabel
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@en
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@nl
P2093
P921
P1476
Acyclovir prophylaxis against ...... ind, placebo-controlled study.
@en
P2093
P304
P356
10.7326/0003-4819-99-6-773
P407
P577
1983-12-01T00:00:00Z